Secondary hemophagocytic lymphohistiocytosis: a case report.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
30 04 2021
Historique:
received: 28 10 2019
accepted: 03 11 2019
entrez: 4 5 2021
pubmed: 5 5 2021
medline: 29 6 2021
Statut: epublish

Résumé

Hemophagocytic lymphohistiocytosis (HLH) is a rare hematologic syndrome presenting either as an inherited life-threatening inflammatory disorder in children or as a secondary disease in adults. Inherited HLH involves inborn defects in lymphocytes and includes autosomal recessive and X-linked disorders characterized by uncontrolled activation of T cells and macrophages and overproduction of inflammatory cytokines. Secondary or acquired HLH occurs in the settings of infections, systemic connective tissue disease and lymphoid malignancies, possibly due to underlying genetic predisposition to develop HLH. The mechanisms leading to secondary HLH have yet to be fully determined and the disease remains frequently undiagnosed and thereby untreated. Herewith we report the case of an 83-year old Caucasian male who referred to our Division of Internal Medicine and Nephrology due to marked asthenia associated with fever, mental confusion, drowsiness and hyporexia, who was ultimately diagnosed with HLH secondary to anaplastic B cell lymphoma. This case report illustrates the difficulties in the diagnostic workup of HLH, mainly related to early identification of the underlying disease and rapid instauration of appropriate therapy.

Identifiants

pubmed: 33944851
doi: 10.23750/abm.v92iS1.8836
pmc: PMC8142758
doi:

Substances chimiques

Cytokines 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2021060

Références

Int J Mol Sci. 2018 Nov 22;19(12):
pubmed: 30469478
Br J Haematol. 2013 Jun;161(5):609-622
pubmed: 23577835
Hematol Oncol Clin North Am. 2015 Oct;29(5):895-902
pubmed: 26461149
Pediatr Blood Cancer. 2008 Nov;51(5):662-8
pubmed: 18623207
Nat Rev Immunol. 2006 Dec;6(12):940-52
pubmed: 17124515
Ann Hematol. 2000 Jul;79(7):378-88
pubmed: 10965786
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265

Auteurs

Lia Salvati (L)

University of L'Aquila . liasal88@gmail.com.

Anita Di Renzo (A)

University of L'Aquila . anita.direnzo90@gmail.com.

Sergio Moscardelli (S)

University of L'Aquila . sergiomoscardelli@gmail.com.

Laura Natali (L)

University of L'Aquila . lauranatali_1960@libero.it.

Ferri Claudio (F)

University of L'Aquila . claudio.ferri@cc.univaq.it.

Angelo Viscido (A)

University of L'Aquila . angelo.viscido@univaq.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH